Btcp Pharma Drug Patent Portfolio

Btcp Pharma owns 2 orange book drugs protected by 16 US patents Given below is the list of Btcp Pharma's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9731869 Container 26 Jan, 2032
Active
US8486972 Sublingual fentanyl spray 27 Apr, 2030
Active
US8486973 Sublingual fentanyl spray 27 Apr, 2030
Active
US10016403 Sublingual fentanyl spray 25 Jan, 2027
Active
US10610523 Sublingual fentanyl spray 25 Jan, 2027
Active
US8835459 Sublingual fentanyl spray 25 Jan, 2027
Active
US8835460 Sublingual fentanyl spray and methods of treating pain 25 Jan, 2027
Active
US9241935 Sublingual fentanyl spray 25 Jan, 2027
Active
US9289387 Method of treating pain by administering sublingual fentanyl spray 25 Jan, 2027
Active
US9642797 Sublingual fentanyl spray and methods of use to treat pain 25 Jan, 2027
Active
US9642844 Sublingual fentanyl spray 25 Jan, 2027
Active
US8216604 Method of managing or treating pain 03 Oct, 2024 Expired
US8889176 Method of managing or treating pain 16 Jan, 2024 Expired
US9078814 Intranasal spray device containing pharmaceutical composition 08 Jan, 2024 Expired
US9814705 Intranasal spray device containing pharmaceutical composition 08 Jan, 2024 Expired
US6432440 Pectin compositions and methods of use for improved delivery of drugs to mucosal surfaces 20 Apr, 2018 Expired


Given below is the list of recent legal activities going on the following drug patents of Btcp Pharma.

Activity Date Patent Number
Patent litigations
Expire Patent 13 May, 2024 US10610523
Expire Patent 29 Apr, 2024 US9289387
Maintenance Fee Reminder Mailed 26 Feb, 2024 US8216604
Maintenance Fee Reminder Mailed 27 Nov, 2023 US10610523
Maintenance Fee Reminder Mailed 13 Nov, 2023 US9289387
Expire Patent 21 Aug, 2023 US9078814
Maintenance Fee Reminder Mailed 06 Mar, 2023 US9078814
Expire Patent 26 Dec, 2022 US8889176
Expire Patent 24 Oct, 2022 US8835460
Expire Patent 15 Aug, 2022 US10016403
Maintenance Fee Reminder Mailed 11 Jul, 2022 US8889176
Maintenance Fee Reminder Mailed 10 May, 2022 US8835460
Maintenance Fee Reminder Mailed 28 Feb, 2022 US10016403
Payment of Maintenance Fee, 4th Year, Large Entity 14 May, 2021 US9814705
Payment of Maintenance Fee, 4th Year, Large Entity 15 Feb, 2021 US9731869


Btcp Pharma's Drug Patent Litigations

Btcp Pharma's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Aug 24, 2015, against patent number US8835460. The petitioner Coalition For Affordable Drugs XI LLC, challenged the validity of this patent, with Insys Pharma, Inc. as the respondent. Click below to track the latest information on how companies are challenging Btcp Pharma's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8486972 August, 2015 Terminated-Denied
(10 Mar, 2016)
Insys Pharma, Inc. Coalition For Affordable Drugs XI LLC
US8835459 August, 2015 Terminated-Denied
(10 Mar, 2016)
Insys Pharma, Inc. Coalition For Affordable Drugs XI LLC
US8835460 August, 2015 Terminated-Denied
(10 Mar, 2016)
Insys Pharma, Inc. Coalition For Affordable Drugs XI LLC


Btcp Pharma Drug Patents' Oppositions Filed in EPO

Btcp Pharma drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jun 18, 2014, by Generics [Uk] Limited. This opposition was filed on patent number EP04701381A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP04701381A Jun, 2014 Generics [UK] Limited Opposition rejected


Btcp Pharma's Family Patents

Btcp Pharma drugs have patent protection in a total of 31 countries. It's US patent count contributes only to 22.1% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Btcp Pharma Drug List

Given below is the complete list of Btcp Pharma's drugs and the patents protecting them.


1. Lazanda

Lazanda is protected by 6 patents, out of which 5 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9731869 Container 26 Jan, 2032
(7 years from now)
Active
US8216604 Method of managing or treating pain 03 Oct, 2024
(2 days ago)
Expired
US8889176 Method of managing or treating pain 16 Jan, 2024
(8 months ago)
Expired
US9078814 Intranasal spray device containing pharmaceutical composition 08 Jan, 2024
(8 months ago)
Expired
US9814705 Intranasal spray device containing pharmaceutical composition 08 Jan, 2024
(8 months ago)
Expired
US6432440 Pectin compositions and methods of use for improved delivery of drugs to mucosal surfaces 20 Apr, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lazanda's drug page


2. Subsys

Subsys is protected by 10 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8486972 Sublingual fentanyl spray 27 Apr, 2030
(5 years from now)
Active
US8486973 Sublingual fentanyl spray 27 Apr, 2030
(5 years from now)
Active
US10016403 Sublingual fentanyl spray 25 Jan, 2027
(2 years from now)
Active
US10610523 Sublingual fentanyl spray 25 Jan, 2027
(2 years from now)
Active
US8835459 Sublingual fentanyl spray 25 Jan, 2027
(2 years from now)
Active
US8835460 Sublingual fentanyl spray and methods of treating pain 25 Jan, 2027
(2 years from now)
Active
US9241935 Sublingual fentanyl spray 25 Jan, 2027
(2 years from now)
Active
US9289387 Method of treating pain by administering sublingual fentanyl spray 25 Jan, 2027
(2 years from now)
Active
US9642797 Sublingual fentanyl spray and methods of use to treat pain 25 Jan, 2027
(2 years from now)
Active
US9642844 Sublingual fentanyl spray 25 Jan, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Subsys's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List